These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15365080)

  • 21. [Chemically-induced paraneoplastic hyperleukocytic lung].
    Le Guen Y; Lebeau B
    Rev Mal Respir; 1999 Dec; 16(6):1139-41. PubMed ID: 10637912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change in mental status in a patient with lung cancer.
    Nadel ES; Brown DF; Wiencek JG
    J Emerg Med; 1998; 16(1):111-4. PubMed ID: 9472768
    [No Abstract]   [Full Text] [Related]  

  • 23. Paraneoplastic hyperpigmentation secondary to lung cancer resolving after chemotherapy.
    Ozgüroğlu M; Tahan V; Ozgüroğlu E; Ozaras R; Demir G
    Am J Clin Oncol; 1999 Oct; 22(5):533-4. PubMed ID: 10521074
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac tamponade as unusual presentation of underlying unrecognized cancer.
    Ballardini P; Margutti G; Zangirolami A; Tampieri M; Incasa E; Gamberini S; Manfredini R
    Am J Emerg Med; 2007 Jul; 25(6):737.e5-6. PubMed ID: 17606115
    [No Abstract]   [Full Text] [Related]  

  • 25. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
    Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer.
    Kim HJ; Kim YJ; Seo MD; Yi HG; Lee SH; Lee SM; Kim DW; Yang SC; Lee CT; Lee JS; Kim YW; Heo DS
    Lung Cancer; 2009 Aug; 65(2):242-6. PubMed ID: 19147252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality.
    Kalemkerian GP
    J Support Oncol; 2007 Jan; 5(1):27-8. PubMed ID: 17265783
    [No Abstract]   [Full Text] [Related]  

  • 28. Tobacco dependence: why should an oncologist care?
    Garces YI; Hays JT
    J Clin Oncol; 2003 May; 21(9):1884-6. PubMed ID: 12721267
    [No Abstract]   [Full Text] [Related]  

  • 29. Age, comorbidity, treatment decision and prognosis in lung cancer.
    Blanco JA; Toste IS; Alvarez RF; Cuadrado GR; Gonzalvez AM; Martín IJ
    Age Ageing; 2008 Nov; 37(6):715-8. PubMed ID: 19004964
    [No Abstract]   [Full Text] [Related]  

  • 30. Resection of lung cancer after contralateral bullectomy in a high risk patient.
    Harvey KP; Adair J; Basoor A; Just J
    Am Surg; 2008 Nov; 74(11):1116-7. PubMed ID: 19062674
    [No Abstract]   [Full Text] [Related]  

  • 31. Arterial carboxyhemoglobin concentrations as a prognostic predictor in elderly patients with advanced non-small-cell lung cancer.
    Yasuda H; Nakayama K; Ebihara S; Asada M; Sasaki T; Suzuki T; Inoue D; Yoshida M; Yamanda S; Yamaya M
    J Am Geriatr Soc; 2006 Apr; 54(4):712-3. PubMed ID: 16686889
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical case seminar: Hypokalemia in a 52-year-old woman with non-small cell lung cancer.
    Mechanick JI; Morris JC
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1769-73. PubMed ID: 7775620
    [No Abstract]   [Full Text] [Related]  

  • 33. A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndrome.
    Noorlander I; Elte JW; Manintveld OC; Tournoy KG; Praet MM; van Meerbeeck JP; Aerts JG
    Lung Cancer; 2006 Feb; 51(2):251-5. PubMed ID: 16352372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osmotic demyelination syndrome associated with 3% hypertonic saline administration.
    Wang AH; Liu XM
    Intern Med J; 2008 Mar; 38(3):219-20. PubMed ID: 18290820
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythema nodosum and lung cancer.
    Perez NB; Bernad B; Narváez J; Valverde J
    Joint Bone Spine; 2006 May; 73(3):336-7. PubMed ID: 16495102
    [No Abstract]   [Full Text] [Related]  

  • 36. Some unusual paraneoplastic syndromes. Case 4. Paraneoplastic nephrotic syndrome in a patient with lung cancer.
    Ebert B; Shaffer K; Rennke H
    J Clin Oncol; 2003 Jul; 21(13):2624-5. PubMed ID: 12829687
    [No Abstract]   [Full Text] [Related]  

  • 37. Palliative benefits of chemotherapy treatment in non-small cell lung cancer may be underappreciated.
    J Support Oncol; 2006 Feb; 4(2):61. PubMed ID: 16499116
    [No Abstract]   [Full Text] [Related]  

  • 38. Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC.
    Sørhaug S; Steinshamn SL; Waldum HL
    Lung Cancer; 2005 Apr; 48(1):137-40. PubMed ID: 15777981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical features of acute exacerbation of interstitial pneumonia associated with lung cancer after chemotherapy].
    Sato K; Shimaoka Y; Hayashi Y; Suzuki N; Ebe Y
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1493-7. PubMed ID: 19755819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.